4.631

0.74% -0.029

Cytek Biosciences Inc (CTKB)

Overview News Price History Option Chain Financials Discussions Forecast

Cytek Biosciences Inc stock is traded at $4.631, with a volume of 62,976. It is down -0.74% in the last 24 hours and up +1.22% over the past month. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Previous Close:

$4.66

Open:

$4.69

24h Volume:

62,976

Relative Volume:

0.05

Market Cap:

$603.12M

Revenue:

$204.17M

Net Income/Loss:

$-74.00M

P/E Ratio:

-8.019

EPS:

-0.5775

Net Cash Flow:

$-12.84M

1W Performance:

-1.37%

1M Performance:

+1.22%

6M Performance:

+4.42%

1Y Performance:

+15.35%

1-Day Range:

$4.59

$4.6936

1-Week Range:

$4.57

$4.92

52-Week Range:

$3.28

$6.18

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name

Cytek Biosciences Inc

Sector

Healthcare (1084)

Industry

Medical Devices (140)

Phone

(877) 922-9835

Address

47215 LAKEVIEW BOULEVARD, FREMONT

Employee

702

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

CTKB's Discussions on Twitter

Compare CTKB vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTKB Cytek Biosciences Inc	4.64	610.92M	204.17M	-74.00M	-12.84M	-0.5775
ABT Abbott Laboratories	115.73	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.00	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.61	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.87	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.91	53.19B	6.30B	1.07B	1.09B	1.8406

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
May-09-25	Downgrade	TD Cowen	Buy → Hold
Jan-31-25	Downgrade	Goldman	Buy → Sell
Dec-14-23	Initiated	Stephens	Overweight
Jul-19-23	Initiated	Raymond James	Mkt Perform
Jan-06-22	Resumed	Piper Sandler	Overweight

View All

Cytek Biosciences Inc Stock (CTKB) Latest News

Aug 20, 2026

Cytek Biosciences CFO William D. McCombe Executes RSU Vesting and Tax Withholding Transactions - Kalkine Media

Aug 20, 2026

Cytek Biosciences Director Glenn P. Muir Converts 3,086 RSUs to Common Stock on August 18, 2026 - Kalkine Media

Aug 20, 2026

Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes - Stock Titan

Aug 20, 2026

Cytek Biosciences (NASDAQ: CTKB) director gains 3,086 no-cost shares - Stock Titan

Aug 20, 2026

Cytek Biosciences (CTKB) director now holds 28,499 shares - Stock Titan

Aug 20, 2026

Cytek Biosciences (CTKB) CTO gets 33,270 shares, surrenders some for taxes - Stock Titan

Aug 20, 2026

Cytek (CTKB) Quarterly Figures: EPS Prints Above Forecast in the Latest Session; Stock Move: Shares Finish 0.96% HigherEstimate Dispersion - Vinanet

Aug 20, 2026

Aug 17, 2026

Cytek Biosciences Balances Growth With Profit Pressures - TipRanks

Aug 17, 2026

Cytek (CTKB) Q2 2026 Earnings Call Transcript - AOL.com

Aug 17, 2026

Aug 12, 2026

Cytek Biosciences (CTKB) awards 241,416 RSUs and 127,118 options to top lawyer - Stock Titan

Aug 12, 2026

Aug 11, 2026

Cytek Biosciences: Recurring Revenue Reaches 35% Of Sales As Installed Base Approaches 4,000 Instruments - Pulse 2.0

Aug 11, 2026

Cytek Biosciences launches Aurora Evo system to drive high-throughput research and small particle detection - Traders Union

Aug 11, 2026

Promising Penny Stocks To Consider In August 2026 - simplywall.st

Aug 11, 2026

Aug 10, 2026

Cytek Biosciences (NASDAQ:CTKB) Trading 8.5% HigherShould You Buy? - MarketBeat

Aug 10, 2026

Aug 08, 2026

Cytek Biosciences, Inc. (8EQ.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Aug 08, 2026

Aug 07, 2026

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Cytek Biosciences (CTKB) and Sight Sciences (SGHT) - The Globe and Mail

Aug 07, 2026

Aug 06, 2026